Skip to main content

Want a detailed portfolio tracker?

PureTech Health plc American Depositary Shares (PRTC) P/E (2020 - 2026)

PureTech Health plc American Depositary Shares (PRTC) P/E from Nov 16, 2020 to Jun 3, 2026. The TTM PureTech Health plc American Depositary Shares (PRTC) P/E is -12.94. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of PureTech Health plc American Depositary Shares (PRTC)

YearP/EChange
2026-12.94+4.69%
2025-12.37+217.40%
2024-3.90-57.24%
2023-9.11-0.34%
2022-9.14-369.14%
20213.40+8.76%
20203.12N/A

Comparison PureTech Health plc American Depositary Shares (PRTC) P/E with competitors

PureTech Health plc American Depositary Shares (PRTC) P/E is -12.94.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.79%
ENLVEnlivex Therapeutics Ltd0.15-101.16%
FGENFibroGen Inc0.24-101.85%
TRAWTraws Pharma Inc0.47-103.65%
FBIOFortress Biotech Inc0.71-105.45%
CHRSCoherus Biosciences Inc0.98-107.56%
ORMPOramed Pharmaceuticals Inc1.47-111.38%
AGENAgenus Inc2.05-115.82%
VIVSVivoSim Labs Inc2.54-119.59%
INVAInnoviva Inc3.19-124.63%
CRMDCorMedix Inc3.65-128.16%
ABEOAbeona Therapeutics Inc4.20-132.48%
VXRTVaxart Inc4.26-132.92%
CVACCureVac N.V.4.45-134.34%
SRPTSarepta Therapeutics Inc4.62-135.72%
GLPGGalapagos NV4.86-137.53%
RIGLRigel Pharmaceuticals4.92-138.00%
ZVRAZevra Therapeutics Inc4.97-138.42%
ABUSArbutus Biopharma Corp5.69-143.98%
CGENCompugen Ltd7.38-157.04%
AUPHAurinia Pharmaceuticals Inc9.25-171.47%
ACADAcadia Pharmaceuticals Inc9.59-174.07%
OMEROmeros Corporation9.88-176.35%
PLXProtalix BioTherapeutics Inc9.91-176.55%
SPROSpero Therapeutics Inc10.73-182.93%
ADMAAdma Biologics Inc11.33-187.53%
SVASinovac Biotech Ltd11.44-188.34%
TBPHTheravance Biopharma Inc11.78-190.97%
HRMYHarmony Biosciences Holdings Inc12.18-194.09%
TGTXTG Therapeutics Inc13.18-201.81%
INCYIncyte Corp13.38-203.38%
SABSSAB Biotherapeutics Inc14.06-208.60%
XOMAXOMA Corp14.95-215.45%
REGNRegeneron Pharmaceuticals Inc14.98-215.72%
PBYIPuma Biotechnology Inc15.05-216.27%
EXELExelixis Inc15.79-222.02%
NAGENiagen Bioscience Inc16.35-226.34%
CPRXCatalyst Pharmaceuticals Inc17.34-233.99%
MDXGMimedx Group Inc17.38-234.23%
ARGXArgen X SE23.07-278.23%
HALOHalozyme Therapeutics Inc23.20-279.23%
XOMAOXOMA Corp25.34-295.79%
VRTXVertex Pharmaceuticals Inc25.66-298.19%
XOMAPXOMA Corp25.67-298.30%
CTMXCytomX Therapeutics Inc25.70-298.52%
ASNDAscendis Pharma A/S26.35-303.59%
RPRXRoyalty Pharma plc - Class A27.50-312.40%
SLNOSoleno Therapeutics Inc29.02-324.14%
LGNDLigand Pharmaceuticals Inc - Class B30.19-333.19%
BMRNBiomarin Pharmaceutical Inc37.51-389.75%
APLSApellis Pharmaceuticals Inc39.02-401.44%
KRYSKrystal Biotech Inc39.70-406.67%
GMABGenmab40.20-410.58%
ONCBeiGene Ltd67.03-617.79%
TECHBio-Techne Corp68.59-629.90%
VCELVericel Corp80.63-722.87%
PHARPharming Group N.V.87.74-777.80%
ALNYAlnylam Pharmaceuticals Inc124.93-1065.12%
TLXTelix Pharmaceuticals Ltd139.89-1180.66%
CORTCorcept Therapeutics Inc158.39-1323.57%